Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Enzyme converting inhibitors. Current knowledge and perspectives]

M Pathé1

  • 1Service de Cardiologie, Hôpital Intercommunal, Poissy.

Presse Medicale (Paris, France : 1983)
|December 9, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infectious events during the course of autoimmune diseases treated with rituximab: A retrospective study of 93 cases].

La Revue de medecine interne·2016
Same author

A study of women who stalk.

The American journal of psychiatry·2001
Same author

Stalking: new constructions of human behaviour.

The Australian and New Zealand journal of psychiatry·2001
Same author

Study of stalkers.

The American journal of psychiatry·1999
Same author

[Obstructive calcification of the aorta].

Presse medicale (Paris, France : 1983)·1999
Same author

Stalking: false claims of victimisation.

The British journal of psychiatry : the journal of mental science·1999
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Angiotensin converting enzyme inhibitors (CEI) effectively treat hypertension and heart failure by lowering resistance. Early use after myocardial infarction significantly reduces mortality, with benefits persisting even after discontinuation.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pharmacology

Context:

  • Hypertension and heart failure are major cardiovascular diseases.
  • Myocardial infarction (MI) and diabetic nephropathy are serious conditions.
  • The renin-angiotensin system plays a role in cardiovascular and renal health.

Purpose:

  • To review the therapeutic applications of angiotensin converting enzyme inhibitors (CEI).
  • To highlight the benefits of CEI in post-MI patients and those with diabetic nephropathy.
  • To explore the potential of CEI in managing atherosclerosis.

Summary:

  • CEI reduce arteriolar resistance, making them logical treatments for hypertension and heart failure.
  • Early administration of CEI post-MI significantly reduces mortality, an effect additive to other therapies.

Related Experiment Videos

  • CEI slow renal failure progression in insulin-dependent diabetes and may inhibit atherosclerosis.

    • Impact:

    • CEI offer substantial mortality reduction in post-MI patients.
    • CEI are crucial in managing macroproteinuric nephropathy in diabetics.
    • Further research is exploring CEI's role in non-insulin-dependent diabetes and atherosclerosis.